Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin-Reference-Cited by-同舟云学术

Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin

Published:2015-04-08 Issue:5 Volume:10 Page:596-605
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:The Clinical Respiratory Journal

Author:

Wang Chen¹²,Zhai Zhenguo¹,Yang Yuanhua¹,Cheng Zhaozhong³,Ying Kejing⁴,Liang Lirong¹,Dai Huaping¹,Huang Kewu¹,Lu Weixuan⁵,Zhang Zhonghe⁶,Cheng Xiansheng⁷,Shen Ying Hu⁸,Davidson Bruce L.⁹,

Affiliation:

1. Beijing Key Laboratory of Respiratory and Pulmonary Circulation; Beijing Institute of Respiratory Medicine; Beijing Chao-Yang Hospital; Capital Medical University; Beijing China

2. Beijing Hospital; Ministry of Health; Beijing China

3. The Affiliated Hospital of Medical College of Qingdao; Shandong China

4. Sir Run Run Shaw Hospital; Affiliated with Zhejiang University; Zhejiang China

5. Peking Union Medical College Hospital; Chinese Academy of Medical Sciences; Beijing China

6. The Affiliated Hospital of Dalian Medical University; Liaoning China

7. Beijing Fuwai Hospital; Chinese Academy of Medical Sciences; Beijing China

8. Baylor College of Medicine; Houston TX USA

9. University of Washington School of Medicine; Seattle WA USA

Funder

China Key Research Projects of the 10th National Five-Year Development Plan

Fund of China 973 Program

Major International Joint Research Project of Natural Science Foundation of China

Fund of Science and Technology of China

Beijing Natural Science Foundation

Beijing Youth Star of Science and Technology Program

Publisher

Wiley

Subject

Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Reference17 articles.

1. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism;Einstein PE Investigators;N Engl J Med,2012

2. Heparin kinetics in venous thrombosis and pulmonary embolism;Hirsh;Circulation,1976

3. Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa;Bauer;J Thromb Haemost,2011

4. Fixed dose subcutaneous low molecular weight heparin vs adjusted dose unfractionated heparin for venous thromboembolism;Erkins;Cochrane Database Syst Rev,2010

5. Heparin pharmacokinetics: increased requirements in pulmonary embolism;Simon;Br J Haematol,1978

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Embolism Complicated by Active Bleeding;PERT Consortium Handbook of Pulmonary Embolism ;2023

2. Influence of aspirin on the CX3CL1/CX3CR1 signaling pathway in acute pulmonary embolism;International Journal of Molecular Medicine;2017-04-26

3. Current Clinical Management Status of Pulmonary Embolism in China;Chinese Medical Journal;2017-02-20